Literature DB >> 18721333

Candida infection in HIV positive patients 1985-2007.

Christian Traeder1, Susann Kowoll, Keikawus Arastéh.   

Abstract

Infection with Candida species remains a major problem in HIV infected patients. The analysis of over 15,000 hospitalisations (1985-2007) in the AVK cohort shows an increasing incidence of non-albicans species in candida esophagitis. Although our analysis shows a decreasing incidence of opportunistic infections like PCP, cerebral toxoplasmosis and others since the introduction of highly active antiretroviral therapy the incidence of candida esophagitis remains as high as in the years before the HAART era. This observation might reflect the development of resistance against fluconazole and the selection of non-albicans species as a consequence of a long-term prophylactic treatment of HIV+ patients over years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721333     DOI: 10.1111/j.1439-0507.2008.01574.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  UPC2 is universally essential for azole antifungal resistance in Candida albicans.

Authors:  Erin M Vasicek; Elizabeth L Berkow; Stephanie A Flowers; Katherine S Barker; P David Rogers
Journal:  Eukaryot Cell       Date:  2014-03-21

2.  Trichosporon inkin Esophagitis: An Uncommon Disease in a Patient with Pulmonary Cancer.

Authors:  Danielle Patrícia Cerqueira Macêdo; Neiva Tinti de Oliveira; Vanessa Karina Alves da Silva; Aline Mary de Almeida Farias; Reginaldo Gonçalves de Lima Neto; Ana Botler Wilheim; Patrícia Cariolano de Oliveira; Nadyr Pedi; Suanni Lemos de Andrade; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2010-09-23       Impact factor: 2.574

3.  Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.

Authors:  Mao-Wang Ho; Yun-Liang Yang; Chih-Chao Lin; Chih-Yu Chi; Hui-Ting Chen; Po-Chang Lin; Li-Yun Hsieh; Chia-Hui Chou; Wen-Li Chu; Chiou-Pyng Wu; Tsai-Ling Lauderdale; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2014-05-08       Impact factor: 2.574

4.  Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

Authors:  Elias Epp; Ghyslaine Vanier; Doreen Harcus; Anna Y Lee; Gregor Jansen; Michael Hallett; Don C Sheppard; David Y Thomas; Carol A Munro; Alaka Mullick; Malcolm Whiteway
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

Review 5.  Gene Ontology and the annotation of pathogen genomes: the case of Candida albicans.

Authors:  Martha B Arnaud; Maria C Costanzo; Prachi Shah; Marek S Skrzypek; Gavin Sherlock
Journal:  Trends Microbiol       Date:  2009-07-03       Impact factor: 17.079

6.  Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.

Authors:  Yu Jia; Ren-Jie Tang; Lin Wang; Xiang Zhang; Ying Wang; Xin-Ming Jia; Yuan-Ying Jiang
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

7.  Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical.

Authors:  Arnaldo Lopes Colombo; Thaís Guimarães; Luis Fernando Aranha Camargo; Rosana Richtmann; Flavio de Queiroz-Telles; Mauro José Costa Salles; Clóvis Arns da Cunha; Maria Aparecida Shikanai Yasuda; Maria Luiza Moretti; Marcio Nucci
Journal:  Braz J Infect Dis       Date:  2013-05-18       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.